Inhibitors of Memapsin 2 Cleavage for the Treatment of Alzheimer's Disease
申请人:Purdue Research Foundation
公开号:US20140066488A1
公开(公告)日:2014-03-06
Proteases such as memapsin 2 are important enzymes, playing roles in a variety of diseases including Alzheimer's Disease. The inventors have developed inhibitors of memapsin 2 and methods of use therefore in the treatment of disease.
Spiro asymmetric induction. 3. Synthesis of optically pure syn- or anti-.alpha.,.beta.-dihydroxy esters by the aldol condensation of chiral glycolate enolates
作者:William H. Pearson、Minn Chang Cheng
DOI:10.1021/jo00390a044
日期:1987.7
LEASSON, W. H.;CHENG, MINN-CHANG, J. ORG. CHEM., 52,(1987) N 14, 3176-3178
作者:LEASSON, W. H.、CHENG, MINN-CHANG
DOI:——
日期:——
Structure-Based Design of Highly Selective β-Secretase Inhibitors: Synthesis, Biological Evaluation, and Protein–Ligand X-ray Crystal Structure
作者:Arun K. Ghosh、Kalapala Venkateswara Rao、Navnath D. Yadav、David D. Anderson、Navnath Gavande、Xiangping Huang、Simon Terzyan、Jordan Tang
DOI:10.1021/jm3008823
日期:2012.11.8
The structure-based design, synthesis, and X-ray structure of protein-ligand complexes of exceptionally potent and selective beta-secretase inhibitors are described. The inhibitors are designed specifically to interact with S-1' active site residues to provide selectivity over memapsin 1 and cathepsin D. Inhibitor 5 has exhibited exceedingly potent inhibitory activity (K-i = 17 pM) and high selectivity over BACE 2 (>7000-fold) and cathepsin D (>250000-fold). A protein ligand crystal structure revealed important molecular insight into these selectivities. These interactions may serve as an important guide to design selectivity over the physiologically important aspartic acid proteases.